By performing phylogenetic analysis on NS3, NS5A and NS5B genes using Sanger sequencing, we recently identified separate episodes of HCV transmission in two healthcare settings: one in patients with acute HCV diagnosis affected by onco-hematologic disease [36] and the second in patients with acute HCV diagnosis with β-thalassemia [31]. This evidence concerns the gene KRAS and hematologic disorder.